Stryker Other Income (Expense) decreased by 87.8% to $62.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.1%, from $64.00M to $62.00M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 5.0% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$70.00M | -$79.00M | -$62.00M | -$61.00M | -$52.00M | $8.00M | -$53.00M | -$56.00M | -$66.00M | -$62.00M | $332.00M | -$49.00M | -$53.00M | -$42.00M | $356.00M | $64.00M | -$97.00M | -$106.00M | $508.00M | $62.00M |
| QoQ Change | — | -12.9% | +21.5% | +1.6% | +14.8% | +115.4% | -762.5% | -5.7% | -17.9% | +6.1% | +635.5% | -114.8% | -8.2% | +20.8% | +947.6% | -82.0% | -251.6% | -9.3% | +579.2% | -87.8% |
| YoY Change | — | — | — | — | +25.7% | +110.1% | +14.5% | +8.2% | -26.9% | -875.0% | +726.4% | +12.5% | +19.7% | +32.3% | +7.2% | +230.6% | -83.0% | -152.4% | +42.7% | -3.1% |